Pharma & Healthcare

Global Clotting Factor Market Research Report 2024

Coagulation factors are various protein components involved in blood coagulation. Its physiological function is to be activated when blood vessels bleed, stick to platelets and plug leaks in blood vessels.
The global Clotting Factor market was valued at US$ 1453.6 million in 2023 and is anticipated to reach US$ 2022 million by 2030, witnessing a CAGR of 4.8% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Clotting Factor, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clotting Factor.
Report Scope
The Clotting Factor market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Clotting Factor market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Clotting Factor companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Amgen
Novartis
Baxter
Britannia
Capricor
CSL Behring
GlaxoSmithKline
Grifol
Eli Lilly
Segment by Type
Clotting Factor I
Clotting Factor II
Clotting Factor III
Clotting Factor IV
Others
Segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Clotting Factor companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Clotting Factor Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Clotting Factor I
1.2.3 Clotting Factor II
1.2.4 Clotting Factor III
1.2.5 Clotting Factor IV
1.2.6 Others
1.3 Market by Application
1.3.1 Global Clotting Factor Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Clotting Factor Market Perspective (2019-2030)
2.2 Clotting Factor Growth Trends by Region
2.2.1 Global Clotting Factor Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Clotting Factor Historic Market Size by Region (2019-2024)
2.2.3 Clotting Factor Forecasted Market Size by Region (2025-2030)
2.3 Clotting Factor Market Dynamics
2.3.1 Clotting Factor Industry Trends
2.3.2 Clotting Factor Market Drivers
2.3.3 Clotting Factor Market Challenges
2.3.4 Clotting Factor Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Clotting Factor Players by Revenue
3.1.1 Global Top Clotting Factor Players by Revenue (2019-2024)
3.1.2 Global Clotting Factor Revenue Market Share by Players (2019-2024)
3.2 Global Clotting Factor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Clotting Factor Revenue
3.4 Global Clotting Factor Market Concentration Ratio
3.4.1 Global Clotting Factor Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Clotting Factor Revenue in 2023
3.5 Clotting Factor Key Players Head office and Area Served
3.6 Key Players Clotting Factor Product Solution and Service
3.7 Date of Enter into Clotting Factor Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Clotting Factor Breakdown Data by Type
4.1 Global Clotting Factor Historic Market Size by Type (2019-2024)
4.2 Global Clotting Factor Forecasted Market Size by Type (2025-2030)
5 Clotting Factor Breakdown Data by Application
5.1 Global Clotting Factor Historic Market Size by Application (2019-2024)
5.2 Global Clotting Factor Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Clotting Factor Market Size (2019-2030)
6.2 North America Clotting Factor Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Clotting Factor Market Size by Country (2019-2024)
6.4 North America Clotting Factor Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Clotting Factor Market Size (2019-2030)
7.2 Europe Clotting Factor Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Clotting Factor Market Size by Country (2019-2024)
7.4 Europe Clotting Factor Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Clotting Factor Market Size (2019-2030)
8.2 Asia-Pacific Clotting Factor Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Clotting Factor Market Size by Region (2019-2024)
8.4 Asia-Pacific Clotting Factor Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Clotting Factor Market Size (2019-2030)
9.2 Latin America Clotting Factor Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Clotting Factor Market Size by Country (2019-2024)
9.4 Latin America Clotting Factor Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Clotting Factor Market Size (2019-2030)
10.2 Middle East & Africa Clotting Factor Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Clotting Factor Market Size by Country (2019-2024)
10.4 Middle East & Africa Clotting Factor Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Detail
11.1.2 Amgen Business Overview
11.1.3 Amgen Clotting Factor Introduction
11.1.4 Amgen Revenue in Clotting Factor Business (2019-2024)
11.1.5 Amgen Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Clotting Factor Introduction
11.2.4 Novartis Revenue in Clotting Factor Business (2019-2024)
11.2.5 Novartis Recent Development
11.3 Baxter
11.3.1 Baxter Company Detail
11.3.2 Baxter Business Overview
11.3.3 Baxter Clotting Factor Introduction
11.3.4 Baxter Revenue in Clotting Factor Business (2019-2024)
11.3.5 Baxter Recent Development
11.4 Britannia
11.4.1 Britannia Company Detail
11.4.2 Britannia Business Overview
11.4.3 Britannia Clotting Factor Introduction
11.4.4 Britannia Revenue in Clotting Factor Business (2019-2024)
11.4.5 Britannia Recent Development
11.5 Capricor
11.5.1 Capricor Company Detail
11.5.2 Capricor Business Overview
11.5.3 Capricor Clotting Factor Introduction
11.5.4 Capricor Revenue in Clotting Factor Business (2019-2024)
11.5.5 Capricor Recent Development
11.6 CSL Behring
11.6.1 CSL Behring Company Detail
11.6.2 CSL Behring Business Overview
11.6.3 CSL Behring Clotting Factor Introduction
11.6.4 CSL Behring Revenue in Clotting Factor Business (2019-2024)
11.6.5 CSL Behring Recent Development
11.7 GlaxoSmithKline
11.7.1 GlaxoSmithKline Company Detail
11.7.2 GlaxoSmithKline Business Overview
11.7.3 GlaxoSmithKline Clotting Factor Introduction
11.7.4 GlaxoSmithKline Revenue in Clotting Factor Business (2019-2024)
11.7.5 GlaxoSmithKline Recent Development
11.8 Grifol
11.8.1 Grifol Company Detail
11.8.2 Grifol Business Overview
11.8.3 Grifol Clotting Factor Introduction
11.8.4 Grifol Revenue in Clotting Factor Business (2019-2024)
11.8.5 Grifol Recent Development
11.9 Eli Lilly
11.9.1 Eli Lilly Company Detail
11.9.2 Eli Lilly Business Overview
11.9.3 Eli Lilly Clotting Factor Introduction
11.9.4 Eli Lilly Revenue in Clotting Factor Business (2019-2024)
11.9.5 Eli Lilly Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Clotting Factor Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Clotting Factor I
Table 3. Key Players of Clotting Factor II
Table 4. Key Players of Clotting Factor III
Table 5. Key Players of Clotting Factor IV
Table 6. Key Players of Others
Table 7. Global Clotting Factor Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Clotting Factor Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Clotting Factor Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Clotting Factor Market Share by Region (2019-2024)
Table 11. Global Clotting Factor Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Clotting Factor Market Share by Region (2025-2030)
Table 13. Clotting Factor Market Trends
Table 14. Clotting Factor Market Drivers
Table 15. Clotting Factor Market Challenges
Table 16. Clotting Factor Market Restraints
Table 17. Global Clotting Factor Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Clotting Factor Market Share by Players (2019-2024)
Table 19. Global Top Clotting Factor Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clotting Factor as of 2023)
Table 20. Ranking of Global Top Clotting Factor Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Clotting Factor Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Clotting Factor Product Solution and Service
Table 24. Date of Enter into Clotting Factor Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Clotting Factor Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Clotting Factor Revenue Market Share by Type (2019-2024)
Table 28. Global Clotting Factor Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Clotting Factor Revenue Market Share by Type (2025-2030)
Table 30. Global Clotting Factor Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Clotting Factor Revenue Market Share by Application (2019-2024)
Table 32. Global Clotting Factor Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Clotting Factor Revenue Market Share by Application (2025-2030)
Table 34. North America Clotting Factor Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Clotting Factor Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Clotting Factor Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Clotting Factor Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Clotting Factor Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Clotting Factor Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Clotting Factor Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Clotting Factor Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Clotting Factor Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Clotting Factor Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Clotting Factor Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Clotting Factor Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Clotting Factor Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Clotting Factor Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Clotting Factor Market Size by Country (2025-2030) & (US$ Million)
Table 49. Amgen Company Detail
Table 50. Amgen Business Overview
Table 51. Amgen Clotting Factor Product
Table 52. Amgen Revenue in Clotting Factor Business (2019-2024) & (US$ Million)
Table 53. Amgen Recent Development
Table 54. Novartis Company Detail
Table 55. Novartis Business Overview
Table 56. Novartis Clotting Factor Product
Table 57. Novartis Revenue in Clotting Factor Business (2019-2024) & (US$ Million)
Table 58. Novartis Recent Development
Table 59. Baxter Company Detail
Table 60. Baxter Business Overview
Table 61. Baxter Clotting Factor Product
Table 62. Baxter Revenue in Clotting Factor Business (2019-2024) & (US$ Million)
Table 63. Baxter Recent Development
Table 64. Britannia Company Detail
Table 65. Britannia Business Overview
Table 66. Britannia Clotting Factor Product
Table 67. Britannia Revenue in Clotting Factor Business (2019-2024) & (US$ Million)
Table 68. Britannia Recent Development
Table 69. Capricor Company Detail
Table 70. Capricor Business Overview
Table 71. Capricor Clotting Factor Product
Table 72. Capricor Revenue in Clotting Factor Business (2019-2024) & (US$ Million)
Table 73. Capricor Recent Development
Table 74. CSL Behring Company Detail
Table 75. CSL Behring Business Overview
Table 76. CSL Behring Clotting Factor Product
Table 77. CSL Behring Revenue in Clotting Factor Business (2019-2024) & (US$ Million)
Table 78. CSL Behring Recent Development
Table 79. GlaxoSmithKline Company Detail
Table 80. GlaxoSmithKline Business Overview
Table 81. GlaxoSmithKline Clotting Factor Product
Table 82. GlaxoSmithKline Revenue in Clotting Factor Business (2019-2024) & (US$ Million)
Table 83. GlaxoSmithKline Recent Development
Table 84. Grifol Company Detail
Table 85. Grifol Business Overview
Table 86. Grifol Clotting Factor Product
Table 87. Grifol Revenue in Clotting Factor Business (2019-2024) & (US$ Million)
Table 88. Grifol Recent Development
Table 89. Eli Lilly Company Detail
Table 90. Eli Lilly Business Overview
Table 91. Eli Lilly Clotting Factor Product
Table 92. Eli Lilly Revenue in Clotting Factor Business (2019-2024) & (US$ Million)
Table 93. Eli Lilly Recent Development
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Clotting Factor Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Clotting Factor Market Share by Type: 2023 VS 2030
Figure 3. Clotting Factor I Features
Figure 4. Clotting Factor II Features
Figure 5. Clotting Factor III Features
Figure 6. Clotting Factor IV Features
Figure 7. Others Features
Figure 8. Global Clotting Factor Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Clotting Factor Market Share by Application: 2023 VS 2030
Figure 10. Hospitals Case Studies
Figure 11. Clinics Case Studies
Figure 12. Ambulatory Surgical Centers Case Studies
Figure 13. Clotting Factor Report Years Considered
Figure 14. Global Clotting Factor Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Clotting Factor Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Clotting Factor Market Share by Region: 2023 VS 2030
Figure 17. Global Clotting Factor Market Share by Players in 2023
Figure 18. Global Top Clotting Factor Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clotting Factor as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Clotting Factor Revenue in 2023
Figure 20. North America Clotting Factor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Clotting Factor Market Share by Country (2019-2030)
Figure 22. United States Clotting Factor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Clotting Factor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Clotting Factor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Clotting Factor Market Share by Country (2019-2030)
Figure 26. Germany Clotting Factor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Clotting Factor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Clotting Factor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Clotting Factor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Clotting Factor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Clotting Factor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Clotting Factor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Clotting Factor Market Share by Region (2019-2030)
Figure 34. China Clotting Factor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Clotting Factor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Clotting Factor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Clotting Factor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Clotting Factor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Clotting Factor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Clotting Factor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Clotting Factor Market Share by Country (2019-2030)
Figure 42. Mexico Clotting Factor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Clotting Factor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Clotting Factor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Clotting Factor Market Share by Country (2019-2030)
Figure 46. Turkey Clotting Factor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Clotting Factor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Amgen Revenue Growth Rate in Clotting Factor Business (2019-2024)
Figure 49. Novartis Revenue Growth Rate in Clotting Factor Business (2019-2024)
Figure 50. Baxter Revenue Growth Rate in Clotting Factor Business (2019-2024)
Figure 51. Britannia Revenue Growth Rate in Clotting Factor Business (2019-2024)
Figure 52. Capricor Revenue Growth Rate in Clotting Factor Business (2019-2024)
Figure 53. CSL Behring Revenue Growth Rate in Clotting Factor Business (2019-2024)
Figure 54. GlaxoSmithKline Revenue Growth Rate in Clotting Factor Business (2019-2024)
Figure 55. Grifol Revenue Growth Rate in Clotting Factor Business (2019-2024)
Figure 56. Eli Lilly Revenue Growth Rate in Clotting Factor Business (2019-2024)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies